Companies Settle Patent Suit Over Vascular Product
The dispute, which began in August 2003, ended with Herbalife entering into a royalty-bearing, nonexclusive license for United Therapeutics’ patents, the company said Monday. The exact terms of the settlement were not disclosed.
Nevada-based Herbalife filed a suit seeking declaratory judgment against United Therapeutics’ subsidiary, Unither Pharma, relating to products that contained the amino acid L-arginine, and Herbalife's...
To view the full article, register now.